Appointment of Directors. The Directors shall be appointed as follows:
Appointment of Directors. Immediately upon the Effective Time, Parent shall, in accordance with Section 2.3(d), require and accept the resignations of those officers and directors of Parent listed on Exhibit C hereto under the heading “Pre-Effective Time,” and shall immediately upon the Effective Time, cause the appointments of those officers and directors of Parent identified in Exhibit C hereto under the heading “Following Notice Filings”, subject to any notice and waiting period requirements of federal law. At the first annual meeting of Parent’s stockholders and thereafter, the election of members of Parent’s Board of Directors shall be accomplished in accordance with the by-laws of Parent.
Appointment of Directors. Immediately upon the Effective Time, Parent shall accept the resignations of the current officers and directors of Parent as provided by Section 8.2(e)(5) hereof, and the persons listed as directors in Exhibit A hereto shall be elected to the Board of Directors of Parent.
Appointment of Directors. In the event of the appointment of a Director nominated in accordance with Clause 6.2, the Shareholders shall vote their Shares to cause the appointment to the Board of the Director so designated for appointment by the appropriate Shareholder.
Appointment of Directors. In the event of the resignation, death, removal or disqualification of a director selected under Section 2, a new director shall promptly be nominated following the procedure originally used to elect the director being replaced and, after written notice of the nomination has been given by the Company to the Stockholders and Investors following the director’s nomination (and such nominee has been designated as provided in Section 2 above), each Stockholder and Investor shall vote its shares of capital stock of the Company to elect such nominee to the Board.
Appointment of Directors. Immediately upon the Effective Time, Parent shall, in accordance with Section 2.3(d), accept the resignations and cause the appointments of those officers and directors of Parent identified in Exhibit C hereto, subject to any notice and waiting period requirements of federal law. At the first annual meeting of Parent’s stockholders and thereafter, the election of members of Parent’s Board of Directors shall be accomplished in accordance with the by-laws of Parent.
Appointment of Directors. 23 5.5 Parent Name Change and Exchange Listing........................................................23 5.6
Appointment of Directors. The STOCKHOLDERS hereby designate [NAME] to serve as a director of VPI effective as of the Closing Date. Representatives of the Founding Companies shall constitute a majority of the directors of VPI immediately following the Closing Date.
Appointment of Directors. The Company hereby covenants and agrees to take such action, promptly following the Closing Date, as is necessary to (i) increase the number of positions on the Board of Directors to seven and (ii) cause an individual designated by Caduceus (any such individual a “Purchaser Designee”) to be appointed to the Board of Directors until the next annual general meeting of the Company. The initial Purchaser Designee shall be Xxxxx Xxxxxxxx, M.D. The Company further covenants and agrees to take such action as is necessary to present another Purchaser Designee, being Xxxxxxxx Xxxx, for election to the Board of Directors of the Company at the Shareholders’ Meeting, and to recommend in the management information circular to be distributed in connection with the Shareholders’ Meeting that shareholders vote in favor of Xx. Xxxx’x election. The Company further covenants and agrees that, provided the OrbiMed Purchasers and their Affiliates hold not less than 5,800,000 Shares, it shall include the two Purchaser Designees on management’s slate of nominees for election to the Board of Directors of the Company at the next ensuing, and each subsequent, annual general meeting of the Company; provided, however, that any vacancies created by the death, resignation or removal of either or both of the Purchaser Designees shall be promptly filled by the Board of Directors upon receipt of instructions from Caduceus (the “Replacement Designees” and together with the Purchaser Designees, the “OrbiMed Designees”). Such Replacement Designees shall serve until the Company’s next ensuing annual general meeting and, at such meeting and each subsequent, annual general meeting of the Company, shall be included on management’s slate of nominees for election to the Board of Directors. The parties agree that the Company’s obligations in connection with this Section 4.12 are subject to each OrbiMed Designee meeting the qualification requirements of the Business Corporations Act (British Columbia), and of the Toronto Stock Exchange and delivering to the Company all documents required pursuant thereto, including a personal information form.
Appointment of Directors. The Board of Directors shall be formed on the date this Contract is signed by both Parties to the JVC. The Board of Directors shall comprise seven (7) members, of which Party A shall appoint two and Party B shall appoint five. Each director shall serve a term of three years, which term can be extended upon expiry by the written confirmation of the Appointing Party. Either Party can by written notice to the JVC, dismiss a director it has appointed. Should any vacancy arise as a result of retirement, dismissal, resignation, sickness, disability or death, the Appointment Party shall appoint a new director for the remainder of the term arising from the vacancy. The JVC shall indemnify and save harmless the directors against all liabilities that may arise by reason of the directors acting as directors of the JVC or any act or omission of the directors.
